Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05367206
PHASE3
Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial
Sponsor: Sun Yat-sen University
View on ClinicalTrials.gov
Summary
Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with albumin-bound paclitaxel and carboplatin followed by chemoradiation therapy (CRT) for stage IIIC cervical cancer patients with carcinoma \>4 cm in greatest dimension and/or lymph node \>2cm in short axis.
Official title: Department of Radiation, Sun Yat-sen University
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
280
Start Date
2022-03-14
Completion Date
2027-03-31
Last Updated
2022-05-10
Healthy Volunteers
No
Interventions
DRUG
Albumin-Bound Paclitaxel
260mg/m2 q3w \*2 circles
DRUG
Carboplatin
AUC 5-6 q3w \* 2 circles
Locations (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdone, China